Form 4: Director Nunnelly Receives Stock Options in National Research Corp (NRC)
SEC Form 4
John N. Nunnelly, a director of National Research Corp, was granted stock options for 10,906 shares on May 8, 2024, as part of the company's 2004 Non-Employee Director Stock Plan.
Summary
- This Form 4 filing reports a transaction by John N. Nunnelly, a director of National Research Corp (NRC).
- On May 8, 2024, Nunnelly was granted stock options to purchase 10,906 shares of NRC common stock at an exercise price of $29.76.
- These options were granted under the Issuer's 2004 Non-Employee Director Stock Plan.
- The options vest on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.
- Following this transaction, Nunnelly directly owns 10,906 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine director compensation disclosure.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule encourages continued service by the director.
Future Outlook
The options vest on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.
Industry Context
Stock option grants to directors are a common practice in publicly traded companies to incentivize and retain board members.
Comparison to Industry Standards
- Stock option grants are a typical component of director compensation packages in publicly traded companies.
- The size of the grant (10,906 shares) would need to be compared to grants at similar-sized companies in the same industry to determine if it is within the normal range.
- Companies like Press Ganey or Advisory Board could be considered peers for comparison of director compensation practices.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of transaction: Director Stock Option (Right to Buy) grant. |
| 05/08/2034 | Expiration date of the Director Stock Option (Right to Buy). |
| 05/10/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.